HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A G Duffy Selected Research

Carcinogenesis

10/2016Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A G Duffy Research Topics

Disease

5Neoplasms (Cancer)
04/2022 - 01/2014
1Carcinogenesis
10/2016
1Colorectal Neoplasms (Colorectal Cancer)
10/2016
1Hepatocellular Carcinoma (Hepatoma)
10/2015
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2014
1Carcinoma (Carcinomatosis)
07/2006

Drug/Important Bio-Agent (IBA)

1Immune Checkpoint InhibitorsIBA
01/2022
1Irinotecan (Camptosar)FDA LinkGeneric
10/2016
1Eukaryotic Initiation Factor-4EIBA
10/2016
1Antisense OligonucleotidesIBA
10/2016
1LY 2275796IBA
10/2016
1Peptide Initiation Factors (Initiation Factor)IBA
10/2016
1Messenger RNA (mRNA)IBA
10/2016
1Immunoglobulin G (IgG)IBA
10/2015
1carotuximabIBA
10/2015
1EndoglinIBA
10/2015
1Sorafenib (BAY 43-9006)FDA Link
10/2015
1Monoclonal AntibodiesIBA
10/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2015
1taxaneIBA
07/2006

Therapy/Procedure

1Precision Medicine
04/2022
1Immunotherapy
01/2022
1Therapeutics
01/2014
1Drug Therapy (Chemotherapy)
07/2006